Autonomix Medical short interest was 50.21% of the float on July 31st, according to new data we received from Benzinga. Short interest totaled 263,441 shares, which was an increase of 327.23% from July 15th.
It is estimated that it would take 1.0 days for short sellers to buy back their shares, with current trading volumes.
Autonomix Medical Hedge Fund Activity
We have seen 7 institutional investors add shares of Autonomix Medical stock to their portfolio, and 11 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GEODE CAPITAL MANAGEMENT, LLC added 152,114 shares (+647.1%) to their portfolio in Q1 2026, for an estimated $59,339
- UBS GROUP AG added 33,370 shares (+26275.6%) to their portfolio in Q1 2026, for an estimated $13,017
- LPL FINANCIAL LLC removed 31,435 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $195,840
- BANK OF MONTREAL /CAN/ removed 25,000 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $155,750
- VIRTU FINANCIAL LLC added 12,884 shares (+inf%) to their portfolio in Q1 2026, for an estimated $5,026
- TWO SIGMA SECURITIES, LLC removed 10,855 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $4,234
- TOWER RESEARCH CAPITAL LLC (TRC) added 313 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,949
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
